Dexamethasone reduces lung eosinophilia, and VCAM-1 and ICAM-1 expression induced by Sephadex beads in rats

European Journal of Pharmacology

Volumn 468, Issue 1, 2003, Pages 59-66

  Ito, Akemi ^a   Miyake, Mio ^a   Morishita, Masashi ^b   Ito, Komei ^b   Torii, Shinpei ^c   Sakamoto, Tatsuo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^c AICHI GAKUSEN UNIVERSITY   (Japan)

Author keywords

Dexamethasone; ICAM 1 (intercellular adhesion molecule); Lung eosinophilia; Sephadex bead; TNF (tumor necrosis factor ); VCAM 1 (vascular cell adhesion molecule)

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; SEPHADEX; VASCULAR CELL ADHESION MOLECULE 1;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BIOACCUMULATION; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; IMMUNOBLOTTING; INFLAMMATION; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REDUCTION; TISSUE DISTRIBUTION; TISSUE LEVEL; UPREGULATION;

EID: 0037728727     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01640-6     Document Type: Article

References (33)

1. Barnes P.J. Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42:1996;3-10.
2. Barnes P.J., Karin M. Nuclear factor-κB - a pivotal transcriptional factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1997;1066-1071.
3. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators of asthma. Pharmacol. Rev. 50:1998;515-596.
4. Birrell M., Hele D., McCluskie K., Webber S., Foster M., Belvisi M.G. Effect of the p38 kinase inhibitor, SB 203580, on Sephadex induced airway inflammation in the rat. Eur. Respir. J. 16:2000;947-950.
5. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P., Francois-Bernard M. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1990;1033-1039.
6. Buyssens N., Loenders B., Van den Bossche R., Herman A. Sephadex induced granulomatous reaction in rats. Exp. Toxicol. Pathol. 47:1995;381-390.
7. Carios T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
8. Das A.M., Williams T.J., Lobb R., Nourshargh S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology. 84:1995;41-46.
9. De Francischi J.N., Conroy D.M., Maghni K., Sirois P. Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs. Br. J. Pharmacol. 110:1993;1381-1386.
10. Fujisawa T., Kato Y., Atsuta J., Terada A., Iguchi K., Kamiya H., Yamada H., Nakajima T., Miyamasu M., Hirai K. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by T(H)2- and T(H)1-derived cytokines. J. Allergy Clin. Immunol. 105:2000;126-133.
11. Gater P.R., Wasserman M.A., Paciorek P.M., Renzetti L.M. Inhibition of Sephadex-induced lung injury in the rat by Ro 45-2081, a tumor necrosis factor receptor fusion protein. Am. J. Respir. Cell Mol. Biol. 14:1996;454-460.
12. Gleich G.J., Flavahan N.A., Fujisawa T., Vanhoutte P.M. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J. Allergy Clin. Immunol. 81:1988;776-781.
13. Guo R., Ward P.A., Jordan J.A., Huber-Lang M., Warner R.L., Shi M.M. Eotaxin expression in Sephadex-induced lung injury in rats. Am. J. Pathol. 155:1999;2001-2008.
14. Haddad E.B., Underwood S.L., Dabrowski D., Birrell M.A., McCluskie K., Battram C.H., Pecoraro M., Foster M.L., Belvisi M.G. Critical role for T cells in sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification. J. Immunol. 168:2002;3004-3016.
15. Harrington P.M., Newton D.J., Williams C.M.M., Hunt J.A., Dearman R.J., Kimber I., Coleman J.W., Flanagan B.F. Eotaxin and eotaxin receptor (CCR3) expression in Sephadex particle-induced rat lung inflammation. Int. J. Exp. Pathol. 80:1999;177-185.
16. Horgan M.J., Ming G.E., Jiang G.U., Rothlein R., Malik A.B. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am. J. Physiol. 261:1991;H1578-H1584.
17. Kleemann R., Deschl U., Dietmann G., Wilhelms O.H., Juchem R., Rebel W., Hartig F. Sephadex induced bronchial hyperreactivity in the rat: hematology, histology, histochemistry and immunohistology of the lung. Exp. Toxicol. Pathol. 48:1996;233-241.
18. Kubin R., Deschl U., Linssen M., Wilhelms O.H. Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholine. Int. Arch. Allergy Immunol. 98:1992;266-272.
19. Laycock S.M., Smith H., Spicer B.A. Airway hyper-reactivity and eosinophilia in rats treated with Sephadex particles. Int. Arch. Allergy Appl. Immunol. 82:1987;347-348.
20. Lemanske R.F., Kaliner M.A. The experimental production of increased eosinophils in rat late-phase reactions. Immunology. 45:1982;561-568.
21. Lo S.K., Everitt J., Gu J., Malik A.B. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest. 89:1992;981-988.
22. Maghni K., Blanchette F., Sirois P. Induction of lung eosinophilia and neutrophilia in guinea pigs following injection of Sephadex beads. Inflammation. 17:1993;537-550.
23. Marik A.B., Lo S.K. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol. Rev. 48:1996;213-229.
24. Nakajima H., Sano H., Nishimura T., Yoshida S., Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1994;1145-1154.
25. Pober J.S., Bevilacqua M.P., Mendrick D.L., Lapierre L.A., Fiers W., Gimbrone M.A. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136:1986;1680-1687.
26. Renzetti L.M., Paciorek P.M., Tannu S.A., Rinaldi N.C., Tocker J.E., Wasserman M.A., Gater P.R. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J. Pharmacol. Exp. Ther. 278:1996;847-853.
27. Schleimer R.P., Sterbinsky S.A., Kaiser J., Bickel C.A., Klunk D.A., Tomioka K., Newman W., Luscinskas F.W., Gimbrone M.A., McIntyre B.W., Bochner B.S. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148:1992;1086-1092.
28. Thornhill M.H., Wellicome S.M., Mahiouz D.L., Lanchbury J.S.S., Kyan-Aung U., Haskard D.O. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. J. Immunol. 146:1991;592-598.
29. Tramontana M., Santicioli P., Giuliani S., Catalioto R.M., Lecci A., Carini F., Maggi C.A. Role of tachykinins in sephadex-induced airway hyperreactivity and inflammation in guinea pigs. Eur. J. Pharmacol. 439:2002;149-158.
30. Walls R.S., Beeson P.B. Mechanism of eosinophilia: IX. Induction of eosinophilia in rats by certain forms of dextran. Proc. Soc. Exp. Biol. Med. 140:1972;689-693.
31. Wardlaw A.J., Kay A.B. The role of the eosinophil in the pathogenesis of asthma. Allergy. 42:1987;321-335.
32. Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 247:1990;456-459.
33. Williams C.M., Smith L., Flanagan B.F., Clegg L.S., Coleman J.W. Tumour necrosis factor-alpha expression and cell recruitment in Sephadex particle-induced lung inflammation: effects of dexamethasone and cyclosporin A. Br. J. Pharmacol. 122:1997;1127-1134.